Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-08-18

Clinical Trial Update: Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating indole-3-carbinol for breast cancer prevention in nonsmoking women at high risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indole-3-Carbinol (Indole-3-Carbinol)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED